OncologyOnline.net

Oncology Xagena

Search results for "Bevacizumab"

An interim analysis of a Phase III study of Avastin ( Bevacizumab ) in combination with Paclitaxel and Carboplatin in advanced, non-small cell lung cancer ( NSCLC ) met its primary efficacy endpoint ...


A study of Bevacizumab ( Avastin ) plus Paclitaxel chemotherapy in first-line metastatic breast cancer met its primary efficacy endpoint of improving progression-free survival, compared to chemothera ...


Data from a study ( E4599 ) of Bevacizumab ( Avastin ) plus Paclitaxel and Carboplatin in first-line non-squamous, non-small cell lung cancer ( NSCLC ) showed the study met its primary efficacy endpoi ...


The results of several clinical studies of Cetuximab ( Erbitux ) have been presented at the American Society of Clinical Oncology ( ASCO ) 41st Annual Meeting. Irinotecan-refractory metastatic co ...


Chemotherapy given in low, frequent doses – a novel strategy called "metronomic" delivery – achieved partial shrinkage of disease in some advanced breast cancer patients when given concurrently with a ...


The therapy Herceptin with chemotherapy in patients with early stage breast cancer significantly increases disease-free survival time in women who test positive for a genetic mutation. The study al ...


Researchers at the Ireland Cancer Center of University Hospitals of Cleveland have found a promising, novel biomarker that may be used to predict the survival of patients with advanced lung cancer and ...


Treatment with chemotherapy and Avastin ( Bevacizumab ), an anticancer drug, is associated with a greater risk of blood clots in patients’ arteries compared with treatment with chemotherapy only. ...


A Phase II clinical study of Bevacizumab ( Avastin ), administered alone or in combination with Irinotecan ( Camptosar ) chemotherapy, demonstrated encouraging six-month progression-free survival and ...


Angiogenesis inhibitors that block a tumor’s development of an independent blood supply have been touted as effective cancer fighters that result in fewer side effects than traditional chemotherapy. ...


Brain cancer patients with the poorest prognosis, those with a type of deadly tumor known as glioblastoma multiforme, may survive longer with a drug that chokes off a tumor’s blood supply. Accordin ...


New research at Schepens Eye Research Institute may help explain why the anticancer drug Avastin ( Bevacizumab ), which targets a growth factor responsible for creation of new blood vessels ( VEGF ), ...


Genetic variations ensure that no two people are exactly alike, nor are their cancers. Researchers now have the tools and the knowledge to predict how individuals will respond to cancer therapy, ena ...


Adding bevacizumab to standard chemotherapy and radiation in patients with rectal cancer fully prevented tumor spread and “normalized” tumor blood vessels enough to enable effective therapy, researc ...


Treatment with the angiogenesis inhibitor Bevacizumab ( Avastin ) improved hearing and alleviated other symptoms in patients with neurofibromatosis type 2 ( NF2 ). In a paper, published in the New ...